John Brancaccio
Vorsitzender bei HEPION PHARMACEUTICALS, INC.
Vermögen: 24 579 $ am 30.04.2024
Profil
John Patrick Brancaccio is currently the Chairman at Hepion Pharmaceuticals, Inc. He is also an Independent Non-Executive Director at OKYO Pharma Ltd., a Director at FermaVir Pharmaceuticals LLC, an Independent Director at Actavia Life Sciences, Inc., an Independent Non-Executive Director at AccuStem Sciences, Inc., and an Independent Non-Executive Director at Tiziana Life Sciences Ltd.
In the past, Mr. Brancaccio served as a Director at Tamir Biotechnology, Inc. from 2004 to 2020.
He was also an Independent Director at Callisto Pharmaceuticals, Inc. from 2004 to 2013.
Additionally, he held positions as a Director at Pawfect Foods, Inc., Director at Active With Me, Inc., Independent Director at Cardiff Oncology, Inc. from 2005 to 2022, Independent Director at Synergy Pharmaceuticals LLC from 2008 to 2019, Chief Financial & Operating Officer at Eline Entertainment Group, Inc. from 2000 to 2002, Chief Financial Officer, Secretary & Treasurer at Memory Pharmaceuticals Corp.
from 2002 to 2004, Chief Financial Officer at Orchestra Medical Ventures LLC, and Chief Financial Officer at Accelerated Technologies, Inc. from 2004 to 2017.
Mr. Brancaccio obtained his undergraduate degree from Seton Hall University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
OKYO PHARMA LIMITED
0,05% | 15.09.2023 | 16 670 ( 0,05% ) | 24 121 $ | 30.04.2024 |
| 19.02.2024 | 352 ( 0,01% ) | 454 $ | 30.04.2024 | |
| 03.07.2018 | 3 ( 0,16% ) | 4 $ | 30.04.2024 | |
| 15.12.2023 | 0 ( -.--% ) | - $ | 30.04.2024 | |
ACCUSTEM SCIENCES INC
-.--% | 31.12.2023 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von John Brancaccio
| Unternehmen | Position | Beginn |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Vorsitzender | 20.02.2024 |
| ACTAVIA LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 01.08.2016 |
| OKYO PHARMA LIMITED | Direktor/Vorstandsmitglied | 10.06.2020 |
| ACCUSTEM SCIENCES, INC. | Direktor/Vorstandsmitglied | 01.03.2021 |
| TIZIANA LIFE SCIENCES LTD | Direktor/Vorstandsmitglied | 01.07.2020 |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Direktor/Vorstandsmitglied | 24.09.2005 |
Ehemalige bekannte Positionen von John Brancaccio
| Unternehmen | Position | Ende |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 09.06.2022 |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Direktor/Vorstandsmitglied | 01.05.2020 |
| SYNERGY PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 01.04.2019 |
| ░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von John Brancaccio
| Seton Hall University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| ELINE ENTERTAINMEN | Consumer Services |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| OKYO PHARMA LIMITED | Health Technology |
| TIZIANA LIFE SCIENCES LTD | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Health Technology |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
FermaVir Pharmaceuticals LLC
FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Health Technology |
| Pawfect Foods, Inc. | Retail Trade |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Health Technology |
Orchestra Medical Ventures LLC
 Orchestra Medical Ventures LLC Investment ManagersFinance Orchestra Medical Ventures LLC (Orchestra Medical Ventures) is a venture capital firm founded in 2001 by Richard P. Geoffrion and Yuval Binur. The firm is headquartered in New Hope, Pennsylvania. | Finance |
Accelerated Technologies, Inc.
 Accelerated Technologies, Inc. Medical DistributorsDistribution Services Accelerated Technologies, Inc. creates and accelerates cardiovascular medical devices. The company was founded by Martin B. Leon and Yuval Binur and is headquartered in Hackensack, NJ. | Distribution Services |
Active With Me, Inc.
 Active With Me, Inc. Miscellaneous Commercial ServicesCommercial Services Active With Me, Inc. provides online resources that seamlessly offer travelers unique, highly relevant and user-friendly information on activity-based travel. Its listings will be provided for product and service providers of interest to the activity-based traveler. The company was founded on December 6, 2012 and is headquartered in Sarnia, Canada. | Commercial Services |
| Actavia Life Sciences, Inc. | |
| AccuStem Sciences, Inc. |